{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:55:53Z","timestamp":1762908953937,"version":"3.45.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.resmer.2021.100844","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T13:40:30Z","timestamp":1623073230000},"page":"100844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trials"],"prefix":"10.1016","volume":"80","author":[{"given":"B.","family":"Dautzenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmer.2021.100844_bib0270","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2021.100844_bib0275","article-title":"The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7)","author":"Simons","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.resmer.2021.100844_bib0280","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S1473-3099(20)30371-6","article-title":"Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study","volume":"20","author":"De Lusignan","year":"2020","journal-title":"Lancet Infectious Diseases"},{"key":"10.1016\/j.resmer.2021.100844_bib0285","unstructured":"Miyara M, Tubach F, Pourcher V, Morelot-Panzini C, Pernet J, Haroche J, et al. Low incidence of daily current tobacco smoking in patients with symptomatic COVID-19. (submitted) https:\/\/www.qeios.com\/read\/WPP19W.3.1 10.32388\/WPP19W.3."},{"key":"10.1016\/j.resmer.2021.100844_bib0290","article-title":"Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France. (submitted)","author":"Zureik","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.resmer.2021.100844_bib0295","first-page":"1650","volume":"22","author":"Berlin","year":"2020","journal-title":"COVID-19 and smoking"},{"key":"10.1016\/j.resmer.2021.100844_bib0300","doi-asserted-by":"crossref","DOI":"10.5802\/crbiol.8","article-title":"A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications Acad\u00e9mie des sciences","volume":"343","author":"Changeux","year":"2020","journal-title":"Comptes-rendus biologies"},{"key":"10.1016\/j.resmer.2021.100844_bib0305","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s42234-020-00051-7","article-title":"Targeting the cholinergic anti-inflammatory pathway with vagus nerve stimulation in patients with Covid-19?","volume":"6","author":"Bonaz","year":"2020","journal-title":"Bioelectron Med"},{"key":"10.1016\/j.resmer.2021.100844_bib0310","article-title":"Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation","volume":"4","author":"Lindson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.resmer.2021.100844_bib0315","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0735-1097(01)01124-X","article-title":"Risk of acute first myocardial infarction and use of nicotine patches in a general population","volume":"37","author":"Kimmel","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.resmer.2021.100844_bib0320","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1017\/S1041610201007888","article-title":"Effects of transdermal nicotine on learning memory verbal fluency concentration and general health in a healthy sample at risk for dementia","volume":"13","author":"Howe","year":"2001","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.resmer.2021.100844_bib0325","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/WNL.0b013e31823efcbb","article-title":"Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial","volume":"78","author":"Newhouse","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.resmer.2021.100844_bib0330","first-page":"47","article-title":"The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease","volume":"7","author":"Snaedal","year":"1996","journal-title":"Dementia"},{"key":"10.1016\/j.resmer.2021.100844_bib0335","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s002130050931","article-title":"Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease","volume":"143","author":"White","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.resmer.2021.100844_bib0340","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0091-3057(95)00043-V","article-title":"Nicotine patches in Alzheimer's disease: pilot study on learning memory and safety","volume":"51","author":"Wilson","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.resmer.2021.100844_bib0345","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-003-1614-8","article-title":"Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment","volume":"171","author":"White","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.resmer.2021.100844_bib0350","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11764-019-00786-6","article-title":"Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study","volume":"13","author":"Vega","year":"2019","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.resmer.2021.100844_bib0355","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1007\/s10803-018-3536-7","article-title":"An Exploratory Trial of Transdermal Nicotine for Aggression and Irritability in Adults with Autism Spectrum Disorder","volume":"48","author":"Lewis","year":"2018","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.resmer.2021.100844_bib0360","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1037\/a0017441","article-title":"Effects of transdermal nicotine on symptoms, moods, and cardiovascular activity in the everyday lives of smokers and nonsmokers with attention-deficit\/hyperactivity disorder","volume":"23","author":"Gehricke","year":"2009","journal-title":"Psychol Addict Behav"},{"key":"10.1016\/j.resmer.2021.100844_bib0365","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/15622970209150616","article-title":"A pilot-controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorder","volume":"3","author":"Shytle","year":"2002","journal-title":"World J Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.resmer.2021.100844_bib0370","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12137","article-title":"Transdermal Nicotine for the Treatment of Mood and Cognitive Symptoms in Nonsmokers With Late-Life Depression","volume":"79","author":"Gandelman","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.resmer.2021.100844_bib0375","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.arcmed.2004.11.010","article-title":"Effects of long-term administration of nicotine and fluoxetine on sleep in depressed patients","volume":"35","author":"Haro","year":"2004","journal-title":"Arch Med Res"},{"key":"10.1016\/j.resmer.2021.100844_bib0380","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00213-006-0516-y","article-title":"Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind placebo-controlled trial","volume":"189","author":"McClernon","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.resmer.2021.100844_bib0385","first-page":"274","article-title":"The effects of nicotine on Parkinson's disease","volume":"43","author":"Kelton","year":"2000","journal-title":"Brain Cogn"},{"key":"10.1016\/j.resmer.2021.100844_bib0390","first-page":"26","article-title":"Poor tolerability of a transdermal nicotine treatment in Parkinson's disease","author":"Lemay","year":"2003","journal-title":"Clin Neuropharmacology"},{"key":"10.1016\/j.resmer.2021.100844_bib0395","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0278-5846(03)00172-6","article-title":"Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease","volume":"28","author":"Lemay","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.resmer.2021.100844_bib0400","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1212\/WNL.57.6.1032","article-title":"Transdermal nicotine in PD: a randomized double-blind placebo-controlled study","volume":"57","author":"Vieregge","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.resmer.2021.100844_bib0405","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1468-1331.2007.01949.x","article-title":"Chronic high dose transdermal nicotine in Parkinson's disease: an open trial","volume":"14","author":"Villafane","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.resmer.2021.100844_bib0410","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/ene.13474","article-title":"High-dose transdermal nicotine in Parkinson's disease patients: a randomized open-label blinded-endpoint evaluation phase 2 study","volume":"25","author":"Villafane","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.resmer.2021.100844_bib0415","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0924-9338(96)88392-1","article-title":"The efficacy of a dose-escalated application of transdermal nicotine plus sulpiride in Tourette's syndrome","volume":"11","author":"Dursun","year":"1996","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.resmer.2021.100844_bib0420","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(94)90388-3","article-title":"Longlasting improvement of Tourette's syndrome with transdermal nicotine","volume":"344","author":"Dursun","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.resmer.2021.100844_bib0425","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4088\/JCP.v62n0908","article-title":"Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study","volume":"62","author":"Silver","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.resmer.2021.100844_bib0430","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/00004583-199612000-00015","article-title":"Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome","volume":"35","author":"Silver","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.resmer.2021.100844_bib0435","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/BF02355071","article-title":"Pilot trial of nicotine patches as an alternative to corticosteroids in ulcerative colitis","volume":"31","author":"Guslandi","year":"1996","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.resmer.2021.100844_bib0440","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00042737-199806000-00014","article-title":"Outcome of ulcerative colitis after treatment with transdermal nicotine","volume":"10","author":"Guslandi","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.resmer.2021.100844_bib0445","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s003840050221","article-title":"Long-term effects of a single course of nicotine treatment in acute ulcerative colitis: remission maintenance in a 12-month follow-up study","volume":"14","author":"Guslandi","year":"1999","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.resmer.2021.100844_bib0450","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM199403243301202","article-title":"Transdermal nicotine for active ulcerative colitis","volume":"330","author":"Pullan","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2021.100844_bib0455","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/qjmed\/hcg007","article-title":"Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis","volume":"96","author":"Richardson","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.resmer.2021.100844_bib0460","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-126-5-199703010-00004","article-title":"Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial","volume":"126","author":"Sandborn","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resmer.2021.100844_bib0465","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199504133321503","article-title":"Transdermal nicotine as maintenance therapy for ulcerative colitis","volume":"332","author":"Thomas","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2021.100844_bib0470","first-page":"392","article-title":"Is transdermal nicotine associated with cardiovascular risk?","volume":"29","author":"Thomas","year":"1995","journal-title":"J R Coll Physicians Lond"},{"key":"10.1016\/j.resmer.2021.100844_bib0475","first-page":"769","article-title":"Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis","volume":"8","author":"Thomas","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.resmer.2021.100844_bib0480","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/00042737-199610000-00016","article-title":"In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells","volume":"8","author":"Madretsma","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.resmer.2021.100844_bib0485","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0008-6363(01)00381-9","article-title":"Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man","volume":"52","author":"Pellegrini","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.resmer.2021.100844_bib0490","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.1365-2362.1998.00344.x","article-title":"Transdermal nicotine inhibits interleukin 2 synthesis by mononuclear cells derived from healthy volunteers","volume":"28","author":"Van Dijk","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.resmer.2021.100844_bib0495","first-page":"674","article-title":"Transdermal nikotinbehandling af colitis ulcerosa: gennemgang af et Cochrane-review [Transdermal nicotine treatment of ulcerative colitis: a survey of a Cochrane review]","volume":"168","author":"Seidelin","year":"2006","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.resmer.2021.100844_bib0500","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.clinthera.2011.01.004","article-title":"Systematic review and meta-analysis of the efficacy and tolerability of nicotine preparations in active ulcerative colitis","volume":"32","author":"Nikfar","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.resmer.2021.100844_bib0505","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1542-3565(05)00849-9","article-title":"A randomized trial of nicotine enemas for active ulcerative colitis","volume":"3","author":"Ingram","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.resmer.2021.100844_bib0510","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cne.22206","article-title":"Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome","volume":"518","author":"Kataoka","year":"2010","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.resmer.2021.100844_bib0515","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1073\/pnas.1419533112","article-title":"Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioural manifestations of Tourette syndrome","volume":"112","author":"Xu","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.resmer.2021.100844_bib0520","unstructured":"APHP. Efficacy of Nicotine in Preventing COVID-19 Infection in Caregivers (NICOVID-PREV). ClinicalTrials NCT04583410. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04583410."},{"key":"10.1016\/j.resmer.2021.100844_bib0525","unstructured":"APHP. Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients. ClinicalTrials NCT04608201. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04608201."},{"key":"10.1016\/j.resmer.2021.100844_bib0530","unstructured":"APHP. Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients (NICOVID-REA). ClinicalTrials NCT04598594. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04598594."}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041221000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041221000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:52:03Z","timestamp":1762908723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041221000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":53,"alternative-id":["S2590041221000337"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2021.100844","relation":{},"ISSN":["2590-0412"],"issn-type":[{"type":"print","value":"2590-0412"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trials","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2021.100844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"100844"}}